Ontology highlight
ABSTRACT:
SUBMITTER: Kimmelman J
PROVIDER: S-EPMC4854630 | biostudies-literature | 2016 Jan
REPOSITORIES: biostudies-literature
Kimmelman Jonathan J Henderson Valerie V
Journal of medical ethics 20151013 1
Moral evaluation of risk/benefit in early phase studies requires assessing the clinical promise of a candidate intervention using preclinical evidence. Yet, there is little to guide ethics committees, investigators, sponsors or other stakeholders morally charged with making these assessments ('evaluators'). In what follows, we draw on published guidelines for preclinical study design to develop a structured process for assessing the clinical promise of new interventions. In the first step, evalu ...[more]